Jun 2026
Quality products
Great products and amazing delivery timing.
Nick Pirollo· US Verified
growth-hormone
Research Use OnlyCJC-1295 / Ipamorelin
5.0 · 1 reviewCore & Skeletal Muscle RestorationMuscle Growth & RecoverySleep Quality Improvement
A blend of CJC-1295, a synthetic GHRH analogue, and Ipamorelin, a selective ghrelin/GHS-R1a receptor agonist. Characterized in pre-clinical literature for their combined action on the somatotropic axis and pulsatile growth-hormone secretagogue pathways. Sold for laboratory research and identification purposes only. Not for human consumption.
Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
$172One-time
Quantity
1
Free shipping over $500
HPLC VerifiedPublished COAUSA · Cold-Chain
Paying by Zelle / Apple Cash
New to sending payment this way? It's quick, and your order is protected:
- Payment confirmed as soon as it lands — usually within minutes during business hours.
- Most orders ship the same day, cold-packed and discreet.
- Every order ships tracked, with an email at each step.
- Questions answered within hours by a real person.
If we ever can't fulfill your order, you're refunded within 1–2 business days.
CJC-1295 / Ipamorelin
$172
Technical Data
Specifications
Specifications
Technical Details
01
Purity99%+ (HPLC, each component)
02
FormLyophilized Powder
03
StorageStore at -20°C. Reconstituted: 2–8°C, use within 14 days.
04
DosageCJC-1295: 2 mg 1–2x/week; Ipamorelin: 100–300 mcg per dose in research models
05
FormatCo-lyophilized blend
06
SourceSynthetic (both components)
07
MechanismGHRH receptor + GHS-R1a dual agonism
08
CJC-1295 MW3647.28 Da (DAC form)
09
CJC-1295 CAS863288-34-0
10
Ipamorelin MW711.86 Da
11
Ipamorelin CAS170851-70-4
Quality Assurance
Certificate of Analysis
Certificate of Analysis
Verified Feedback
Reviews
5.0
1 verified review
5★
1
4★
0
3★
0
2★
0
1★
0
1 review
Research Overview
About CJC-1295 / Ipamorelin
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analogue that employs Drug Affinity Complex (DAC) technology to achieve covalent albumin binding in circulation, extending its biological half-life from minutes to approximately 6–8 days. This sustained presence enables continuous stimulation of pituitary somatotrophs and prolonged elevation of both growth hormone and IGF-1 levels in research models.
Ipamorelin is a pentapeptide growth hormone secretagogue receptor (GHS-R1a) agonist that triggers GH release through the ghrelin signaling pathway — mechanistically independent of GHRH. Its defining characteristic is selectivity: unlike earlier secretagogues such as GHRP-6, ipamorelin stimulates growth hormone release with minimal concomitant increases in cortisol, prolactin, or ACTH, producing a cleaner pharmacological profile.
The combination leverages convergent signaling on somatotroph cells — simultaneous GHRH receptor and ghrelin receptor activation produces synergistic GH pulse amplification exceeding either agent alone. ROEHN supplies this blend at 99% HPLC-verified purity (each component) as a co-lyophilized powder, supporting research into IGF-1 kinetics, body composition, sleep architecture, and recovery in aging and performance models.
